Common side effects include: Not just because you are overweight or have severe obesity means you automatically qualify for tirzepatide
**Considering a GLP-1 medication for weight loss?** Licensed providers on Klarity Health can evaluate your eligibility and prescribe online no in-person visit needed
Get the latest version of the List The List is updated at least annually
For instance, Cigna reported a trailing price-to-earnings ratio around 9.1 as referenced by GuruFocus on 06/03/2026, which can be compared with higher multiples often seen at larger diversified peers such as UnitedHealth Group, while Cigna's 52-week trading range from about USD 239.51 to USD 338.89 shows that its current level near USD 272 is below both that recent high and some consensus price targets in the sector as compiled by certain analyst aggregators
In addition to established efficacy for glycaemic control and weight loss, there has been growing enthusiasm surrounding the cardioprotective effects of GLP-1 agonists, as demonstrated from their superiority to placebo in multiple large studies in preventing major cardiovascular adverse events, namely reduced rates of myocardial infarcts, stroke, and rates of revascularisation procedures (Table 2)
Zepbound has quickly gained attention as a powerful weight-loss medication
:format(webp))
